Disease management
It is the global multilingual version of the Japanese device NouKNOW.
2022 Look Ahead
Glooko CEO Russ Johannesson predicts that the growth in digital health funding will continue this year, and that the push toward interoperability will be critical for the space.
SugoSure targets patients with type 2 diabetes below 65 years old.
The consumer app enables users to monitor their own heart rhythm round the clock.
Impeto’s SUDOSCAN technology for monitoring peripheral neuropathies is included in Withings’ recently announced Body Scan smart scale.
The company said the smart scale will be available in the latter half of 2022 following regulatory clearance.
2022 Look Ahead
After another rough year for the healthcare system, startups are using the growth of virtual care to manage chronic conditions and expand primary care.
The research targets people with complex regional pain syndrome, post-stroke pain, and other pain-induced conditions.
The company emerged from stealth in August with $41 million.
Also, AXA Hong Kong is offering limited time free trial of Mind Healer online mental health consultation on its mobile app.